Head of Department Dr. Thasee Pillay, FCS.CTh(SA), FRCS, MB

Adult cardiac surgery

Head of Department of CT Surgery, 2008 Clinical Director (Division Chief) of CT services, 2010-14 Director of College of Clinical Perfusion Scientists, RCS, 2014 Chief of Cardiac Surgery, BGS Global Bengaluru – 2017 Chief Medical Officer, BioVentrix Considered expert Beating Heart CABG Mini access AVR Suture less AVR (world leader and master proctor) Heart and Lung Transplantation Mechanical Circulatory Support for heart failure Enhanced Recovery in Cardiac Surgery (world pioneer) Robotic CABG (only practice in the UK) Hybrid LV Reconstruction Trans catheter closure of Paravalvular leaks Worldwide proctor for the Perceval suture-less AVR, training and assessing USA surgeons. This involves all states including prominent centres such as the Texas Heart Institute, Johns Hopkins, Cedars Sinai in Los Angeles. Appointment as Master proctor in July 2017 (the only 1 outside Europe at the time) Currently leading the ALIVE Trial, an FDA Pivotal trial for treatment of ischaemic Heart Failure. Enrolment will be concluded in Q3 2021. Proctoring almost all European commercial and trial cases for Revivent. Extensive clinical, administrative and management experience in Cardiothoracic Sur-gery locally, nationally and internationally. Widely connected to and involved with the: • Society for Cardiothoracic Surgeons of GB and Ireland • Cardiothoracic Surgery (South Africa) • World Society of Cardiothoracic Surgery • International Society of Minimally Invasive Cardiothoracic Surgery • Society for Minimally Invasive Cardiothoracic Surgery of India • Indian Society for Heart Failure and Transplantation • The ARTS trial – 10-year outcomes with arterial revascularization

200 Euro Conversation Price
  • Current job Chief of Cardiac Surgery, BGS Global Bengaluru and Chief Medical Officer at BioVentrix, UK
  • Speciality Adult cardiac surgery
  • Experience 30 Years
  • Language English,
  • Country United Kingdom